SEC Obtains Final Judgment Against Ex-Pharmaceutical Employee Charged With Insider Trading
July 31, 2025
July 31, 2025
WASHINGTON, July 31 -- The Securities and Exchange Commission issued the following litigation release (No. 1:24-cv-12316; D. Mass. filed Sept. 10, 2024) involving Dishant Gupta:
* * *
On July 29, 2025, the United States District Court for the District of Massachusetts entered a final consent judgment against New Jersey resident Dishant Gupta. The SEC previously charged Gupta with insider trading ahead of an announcement that Ipsen Biopharmaceuticals, Inc., then Gupta� . . .
* * *
On July 29, 2025, the United States District Court for the District of Massachusetts entered a final consent judgment against New Jersey resident Dishant Gupta. The SEC previously charged Gupta with insider trading ahead of an announcement that Ipsen Biopharmaceuticals, Inc., then Gupta� . . .